11 completed, 2 unknown, 2 withdrawn, 1 terminated. 16 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 16 | Completed 11, Unknown 2, Withdrawn 2, Terminated 1 |
| Phase 2 | 2 | Completed 2 |
Follow Fibrinogen: new trials by email Literature Review of Fibrinogen trials Research Report on Fibrinogen
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| FIB Grifols Congenital Deficiency for On-demand Treatment and Surgical Prophylaxis FIB Grifols - Congenital Afibrinogenemia, Hypofibrinogenemia | Phase 3 | Withdrawn | Instituto Grifols, S.A. | 2023-12-01 | 2023-10-23 | |
| Fibrinogen Early In Severe Trauma StudY II Fibrinogen Concentrate, Cryoprecipitate - Trauma, Haemorrhagic Shock | Phase 3 | Completed | Australian and New Zealand Intensive Care Research Centre | 900 | 2022-11-21 | 2026-09-09 |
| In Vivo Effects of Fibrinogen Concentrate (FC) Versus Cryoprecipitate on the Neonatal Fibrin Network Structure After Cardiopulmonary Bypass (CPB) Fibrinogen Concentrate (FC), Cryoprecipitate - Hemostasis | Phase 3 | Completed | Emory University | 36 | 2019-08-13 | 2024-02-20 |
| Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency Octafibrin - Congenital Fibrinogen Deficiency | Phase 3 | Completed | Octapharma | 15 | 2015-12-01 | 2021-01-15 |
| Prospective Double Blinded Randomized Control Study of the Use of Fibrinogen in High-Risk Cardiac Surgery Fibrinogen - Cardiac Complication During Procedure | Phase 3 | Completed | Nova Scotia Health Authority | 62 | 2014-02-01 | 2020-05-22 |
| The Efficacy of the Administration of Fibrinogen in Liver Transplantation Fibrinogen, Saline - Intraoperative Bleeding | Phase 3 | Unknown | Hospital Universitari de Bellvitge | 132 | 2012-07-01 | 2014-12-04 |
| The Clinical Effect of i-FACTOR® Versus Allograft in Non-instrumented Posterolateral Spondylodesis Operation in the Elderly With Spinal Stenosis Due to Degenerative Spondylolisthesis i-FACTOR - Spinal Stenosis | Phase 3 | Unknown | Sygehus Lillebaelt | 108 | 2012-03-01 | 2016-09-07 |
| RETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen Plasma Fibrinogen concentrate, Prothrombin complex concentrate and FXIII concentrate, Fresh Frozen Plasma blood type 0, A, B and AB - Major Trauma | Phase 3 | Terminated | Medical University Innsbruck | 100 | 2012-03-01 | 2016-03-23 |
| Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery Fibrinogen Concentrate (Human) (FCH), Placebo - Surgical Blood Loss, Postoperative Blood Loss | Phase 3 | Completed | CSL Behring | 152 | 2012-01-01 | 2014-09-18 |
| The ZEro PLASma Trial (ZEPLAST): Avoidance of Fresh Frozen Plasma in Cardiac Surgery Fibrinogen, Saline solution, Prothrombin complex - Heart Disease | Phase 3 | Completed | IRCCS Policlinico S. Donato | 119 | 2011-11-01 | 2015-03-31 |
| Fibrinogen Concentrate as Initial Treatment for Postpartum Haemorrhage: A Randomised Clinically Controlled Trial Fibrinogen Concentrate, Isotonic Saline - Postpartum Haemorrhage | Phase 2 / Phase 3 | Completed | Copenhagen University Hospital at Herlev | 249 | 2011-05-01 | 2013-09-20 |
| Haemocomplettan® P During Elective Complex Cardiac Surgery Haemocomplettan® P, Human albumin (Placebo) - Fibrinogen Deficiency in Complex Cardiac Surgery | Phase 2 / Phase 3 | Completed | Isala | 120 | 2011-02-01 | 2014-12-16 |
| Fibrinogen Concentrate (Human) - Efficacy and Safety Study Fibrinogen Concentrate, Human (FCH), Cryoprecipitate - Afibrinogenemia, Hypofibrinogenemia | Phase 3 | Withdrawn | CSL Behring | 2009-10-01 | 2023-02-06 | |
| TachoSil Versus Standard Surgical Treatment for Air Leakage in Pulmonary Lobectomy (TC-021-IM) Fibrinogen (human) + thrombin (human) (TachoSil) - Pulmonary Diseases, Intraoperative Complications | Phase 3 | Completed | Nycomed | 2006-02-01 | 2012-05-07 | |
| TachoSil Paediatric Liver Trial (TC-019-IN) Fibrinogen human (TachoSil) - Liver Diseases | Phase 3 | Completed | Nycomed | 16 | 2005-10-01 | 2012-05-07 |
| TachoComb S Versus Standard Surgical Treatment in Surgical Resection of Renal Tumour (TC-015-IN) Fibrinogen (human) + thrombin (human) (TachoSil) - Surgical Resection of Superficial Renal Tumour | Phase 3 | Completed | Takeda | 170 | 2012-08-03 |
Hemostatic Disorders (3) · Afibrinogenemia (2) · Blood Loss, Surgical (2) · Heart Diseases (1) · Hemorrhage (1) · Intraoperative Complications (1) · Liver Diseases (1) · Lung Diseases (1) · Postoperative Hemorrhage (1) · Postpartum Hemorrhage (1) · Shock, Hemorrhagic (1) · Signs and Symptoms (1) · Spinal Stenosis (1) · Thrombosis (1) · Wounds and Injuries (1)
CSL Behring (2) · Nycomed (2) · Australian and New Zealand Intensive Care Research Centre (1) · Copenhagen University Hospital at Herlev (1) · Emory University (1) · Hospital Universitari de Bellvitge (1) · IRCCS Policlinico S. Donato (1) · Instituto Grifols, S.A. (1) · Isala (1) · Medical University Innsbruck (1) · Nova Scotia Health Authority (1) · Octapharma (1) · Sygehus Lillebaelt (1) · Takeda (1)
Denmark (6) · Austria (2) · Canada (2) · Italy (2) · Australia (1) · Brazil (1) · Czechia (1) · Finland (1) · Germany (1) · India (1) · Iran (1) · Japan (1) · Lebanon (1) · Netherlands (1) · New Zealand (1)
Anne J. Wikkelsoe, MD (1) · Antoni Sabate, MD (1) · Arash Afshari, MD (1) · Arno P Nierich, MD, PhD. (1) · Cristina Solomon, MD (1) · Hellen McKinnon Edwards, M.D. (1) · Jakob Stensballe, MD, PhD (1) · Jens Langhoff-Roos, MD, DmSc (1) · Laura Downey, MD (1) · Marco Ranucci, MD (1) · Michael K Jacobsen, MD (1) · Myron Kwapisz, MD (1) · Niels Rahe-Meyer, MD, PhD (1)
PMID 22805300, PMID 25586727, PMID 26037084, PMID 26880105, PMID 27317703, PMID 28241354, PMID 28457980, PMID 28990201, PMID 30462259, PMID 37919695, PMID 39116012, PMID 39152310, PMID 40420619
2004 (2), 2009 (1), 2018 (1)